>
CASE STUDY 1
Parenteral dosage form development of a highly insoluble molecule
>
CASE STUDY 2
Salt form optimization and lyophilized parenteral formulation development
>
CASE STUDY 3
Oral liquid formulation development
>
CASE STUDY 4
Accelerated stability studies to support a screening IND
>
CASE STUDY 5
Lead Optimization: Solubility and formulation screen for efficacy and PK studies
Request Information
To download our comprehensive brochure of IND-enabling services,
click here
.
Name:
Email:
Telephone:
Comments:
© 2009 Wolfe Laboratories, Inc. All rights reserved.
